FdaApplication
ANDA 214785
Identifiers
- fda_app_no: ANDA214785
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | ANDA |
| approval_date | 2021-01-29 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE;INJECTION |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | 1MG/ML | INJECTABLE;INJECTION |
2 products